Executive Management

 Loibner 2017

Hans Loibner, Chief Executive Officer

PhD in Organic Chemistry from the University of Vienna. More than 20 years in R&D management at Sandoz/Novartis; Founded and developed the biotech company Igeneon (cancer immunotherapy). Main responsibilities: Executive Management.

> contact

 pld 180119gr

Peter Llewellyn-Davies, Chief Financial Officer

CFO/CBO with an over 25 year track record in financing activities, international M&A deals, company turnarounds, licensing transactions, in particular in healthcare industries including Wilex and Medigene (Link to CV). Main responsibilities: Finance, Business Development, Corporate Communications, Legal Affairs

> contact



Extended Management Board

 Oliver Mutschlechner

Oliver Mutschlechner,  Chief Development Officer
PhD in Biochemistry / Biotechnology (Technical University of Vienna). Over 20 years of experience in development of biologicals in R&D, pharma and biotech (Octapharma, Intercell, Apeiron). Positions in R&D, QC/QA, qualified person, regulatory affairs and management. Strong background in generating value by successful transition from early development to global commercialization.

> contact

 Kerstin Westritschnig  

Kerstin Westritschnig, Chief Medical Officer
MD from the University of Vienna, specialised in Immunology, 16 years experience in R&D in academia and industry. She worked for Sanochemia and was Vice President Clinical Development for Intercell and Valneva before she joined Apeiron.

> contact